Infused Drinks Offer Consumers a New Way to Ingest Cannabis
NEW YORK, Aug. 15, 2019 /PRNewswire/ -- Each year, health officials conduct new clinical trials to uncover the next generation of medical treatments. Recently, cannabidiol or CBD has become an increasingly popular option because of its therapeutic effects. Additionally, CBD can be used for both recreational and medical purposes. Predominantly, the CBD medical sector is expected to account for the majority of the overall industry as, specifically, the therapeutic grade segment is expected to be the primary driver for the market. For instance, in 2018, the therapeutic grade segment accounted for 58% of the global CBD market. The compound is now primarily being used to treat neuropsychiatric disorders as well as other chronic conditions. And notably, the fibromyalgia segment dominated the industry in 2018 with a market valuation of USD 686.19 Million. Additionally, the CBD industry was primarily driven by the increasing instances of physiological disorders among young adults, while sympt
[Read more]
| Impact snapshot | Event time: | ACB | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ACB alerts
ACB alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACB alerts
High impacting Aurora Cannabis, Inc news events
Weekly update
A roundup of the hottest topics
ACB
News
- ROSEN, A LEADING LAW FIRM, Reminds Aurora Cannabis Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact Firm - ACBPR Newswire
- Aurora Cannabis Forecasts Sales At High End, But Marijuana Stocks Fall [Investor's Business Daily]Investors Business Daily
- Aurora Cannabis Expects Q4 Revenue at High End of Guidance [TheStreet.com]TheStreet.com
- Aurora Cannabis receives final base shelf prospectus; reiterates fiscal Q121 guidance [Seeking Alpha]Seeking Alpha
- Aurora Cannabis sees Q1 revenue coming in at high end of $60 million to $64 million range [MarketWatch]MarketWatch
- More
ACB
SEC Filings
- 10/30/20 - Form 6-K
- 10/29/20 - Form F-10/A
- 10/27/20 - Form 6-K
- ACB's page on the SEC website
- More